Peptides for Longevity: What the Research Actually Supports
Most things sold under the "longevity" label have thin evidence at best. Longevity peptides are no different from the rest of the supplement market in that regard, and some of the claims you will find in forums and vendor copy are far ahead of what the research actually shows. This guide covers the peptides where the evidence is substantial enough to take seriously, what the evidence actually says (not what it is interpreted to say), and how they fit together into a coherent approach.
The short version: Epithalon and GHK-Cu have the strongest research bases. MOTS-c is compelling but earlier-stage. Selank and Dihexa address cognitive aging specifically. BPC-157 and TB-500 extend into structural longevity. None of these are magic. All of them are targeting specific, identifiable mechanisms of cellular aging, and that is the right framework for thinking about them.
What Makes a Peptide "Longevity" Relevant
Best vendor for Epithalon right now: Amino Club
10mg vial, $29.99 per vial ($3.00 per mg), list price checked 2026-09-08. The vendor Bureau readers order from most this year, lowest price per mg on most of what we track, batch COA on every product page. Partner code 100 at checkout takes 20% off a first order there, and keeps the order counted for the Bureau. Research use only.
Check price at Amino Club Compare all vendorsCellular aging proceeds through several parallel mechanisms: telomere shortening (which limits how many times a cell can divide), mitochondrial dysfunction (which reduces energy production and increases oxidative damage), accumulation of senescent cells (which secrete inflammatory signals that damage surrounding tissue), declining regenerative capacity (stem cell exhaustion), and chronic low-grade inflammation.
Calculate your draw for any compound on this page
Pick the peptide, enter your vial, water and dose, and get the exact syringe mark plus doses per vial. Twenty-seven compounds, free, no signup.
Open the peptide calculator peptidedosingcalc.com, the Bureau's independent toolA longevity peptide, to be worth the label, should demonstrably affect at least one of these mechanisms. The strongest candidates address multiple mechanisms at once or act at upstream regulatory points that influence several downstream processes simultaneously.
The Compounds With Real Evidence
Epithalon Strongest human data
The anchor compound for most longevity stacks. Developed from pineal gland research by Dr. Khavinson, Epithalon is a synthetic tetrapeptide (AEDG) that activates telomerase in cell culture and has demonstrated a 28% reduction in mortality over 10 to 12 years in elderly subjects. The research is from one group and has replication limitations, but it is more human data than any other longevity peptide can claim. Sleep quality improvements from its melatonin-regulatory effects are the most immediately noticeable effect during a cycle.
Not sure which of these you actually need?
Answer four questions about your goal, experience and budget and the Stack Builder shows you a matched research protocol on screen, with the compounds, cycle shape and vendor picks from the six vendors we score.
Build your stack, 2 minutesStandard protocol: 5 to 10mg daily via subcutaneous injection for 10 to 20 days, 1 to 2 cycles per year.
Full Epithalon guide →GHK-Cu (Copper Peptide) Strong multi-mechanism data
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has one of the most interesting mechanistic profiles in the longevity category. It naturally declines with age, and supplementation has been shown to activate over 4,000 genes associated with tissue regeneration and suppress genes associated with cancer and inflammation. Robust evidence for skin and collagen applications. Neuroprotective effects in animal models. Antioxidant activity that directly counters oxidative telomere damage.
GHK-Cu is one of the few longevity peptides where topical application has real evidence behind it, making it accessible without injectable protocols.
Full GHK-Cu guide →MOTS-c Promising human data
MOTS-c is a mitochondrially-encoded peptide that acts as a signaling molecule between mitochondria and the nucleus. Circulating MOTS-c levels decline with age. In human studies, MOTS-c supplementation has shown improvements in insulin sensitivity and metabolic flexibility. Mitochondrial dysfunction is one of the primary hallmarks of cellular aging, and a peptide that supports mitochondrial signaling directly is mechanistically compelling.
Relatively newer compound with less long-term data than Epithalon or GHK-Cu, but the mitochondrial angle fills a gap in what the other longevity peptides address.
Full MOTS-c guide →Selank Clinical data (anxiety + neuroprotection)
Selank is a synthetic analogue of the human tuftsin protein, developed and clinically studied in Russia for anxiety and cognitive enhancement. For longevity purposes, the interest is in its neuroprotective effects and its ability to modulate BDNF (brain-derived neurotrophic factor), which declines with age and is associated with cognitive decline. Not a primary longevity compound, but a strong addition for anyone focused on cognitive aging specifically.
One of the easier-to-use longevity compounds because of its intranasal route availability alongside injectable administration.
Full Selank guide →Dihexa Animal data, limited human
Dihexa is a small peptide derived from angiotensin IV research that works through the HGF/MET signaling pathway to promote synaptogenesis, the formation of new connections between neurons. Animal research showed cognitive enhancement effects that some researchers described as orders of magnitude more potent than BDNF itself for certain memory tasks. Human data is thin. Primarily of interest for cognitive longevity applications and as a neuroprotective compound.
More speculative than the other entries on this list. Worth following as the research develops.
Full Dihexa guide →BPC-157 and TB-500 Recovery and structural longevity
These are primarily recovery peptides, but their relevance to longevity is structural: maintaining tendon, ligament, and connective tissue health as aging degrades it. Losing the ability to train effectively is one of the major mechanisms through which aging compounds. BPC-157 and TB-500 support tissue regeneration and recovery capacity, extending the functional training window. They belong in a comprehensive longevity stack for this reason, even if they are not "anti-aging" in the cellular biology sense.
TB-500 vs BPC-157 comparison →Building a Longevity Stack
A coherent longevity stack addresses aging through multiple mechanisms simultaneously rather than betting everything on one compound. The way to think about it is by mechanism layer:
A layered longevity approach
- Telomere layer: Epithalon, cycled twice yearly (5 to 10mg daily for 10 to 20 days)
- Cellular signaling layer: GHK-Cu, topical or low-dose injectable (1 to 2mg, 2 to 3x weekly)
- Mitochondrial layer: MOTS-c, run 2 to 3x weekly (0.5 to 1mg per injection)
- Cognitive layer: Selank, intranasal or injectable on training or high-demand days
- Structural layer: BPC-157 and TB-500, cycled quarterly or when recovery is declining
Most people starting with longevity peptides do not run the full stack. The typical entry point is Epithalon for one cycle to understand how the compound affects sleep and recovery, then adding GHK-Cu for ongoing use because of its broader accessibility. The full stack is for experienced users who have already characterised how each compound affects them individually.
The stack-builder quiz on the site can help identify which compounds match your specific goals. Visit the stack builder to generate a personalised protocol.
Sourcing Longevity Peptides
The longevity category has higher quality variance than mainstream peptides like BPC-157 and TB-500 because the market is smaller and testing infrastructure is less standardized among vendors. Epithalon in particular is a compound where substandard product is more common than with recovery peptides. Always verify the Certificate of Analysis from a named third-party lab before running a longevity cycle.
Vendors with consistent quality documentation across the longevity peptide category include Apollo Peptide Sciences and Amino Club. See the full 2026 vendor scorecard for current rankings and availability by compound.
The 2026 Regulatory Context
The FDA's April 2026 reclassification of several peptides, including TB-500, from Category 1 to Category 2 compounds reflects increased regulatory attention on the research peptide category broadly. GHK-Cu, MOTS-c, Selank, and Epithalon are not among the specifically targeted compounds in recent reclassifications, but the regulatory environment for the category as a whole is shifting. Sourcing from vendors with strong compliance documentation is more important now than it was 18 months ago, not less.
In depth: Top 10 Peptides for Anti-Aging in 2026: The Bureau's Ranked List
Anti-aging peptides have moved from fringe biohacking forums into mainstream longevity protocols over the past three years. The reason is simple. The clinical data on several of these compounds is now strong enough that physicians at high-end longevity clinics routinely prescribe them, and the price has dropped to where motivated researchers can run their own protocols for $50 to $300 a month per peptide.
This is the Bureau's ranked list for 2026. We weighted the rankings by clinical evidence, real-world results, side effect profile, and how easy it is to source a clean batch with verifiable third-party testing. Anything that scored well on all four made the list.
How We Ranked These Peptides
Three factors drove placement. Strength of human or primate trial data on the specific anti-aging mechanism the peptide targets. Reproducibility of self-reported results across long-running peptide communities and clinical case studies. Practical accessibility, meaning you can actually buy a tested batch at a sane price.
Compounds with strong mechanisms but thin human data were ranked lower than compounds with weaker theoretical mechanisms but solid human results. Anti-aging is a long game and theoretical elegance does not equal lived improvement.
1Epitalon
Epitalon is the closest thing the peptide world has to a bona fide longevity compound. The Russian gerontologist Vladimir Khavinson ran clinical work spanning two decades showing that Epitalon lengthens telomeres, normalizes melatonin secretion, and in elderly subjects reduced all-cause mortality over follow-up periods.
Mechanism: Activates telomerase in somatic cells, restoring some telomere length lost to cellular division.
Typical protocol: 5 to 10mg subcutaneous daily for 10 to 20 days, run two to four times a year.
Cost: $80 to $120 per cycle.
Why it ranks first: Hard endpoints in human studies and a mechanism that hits the most fundamental aging clock we know about.
2GHK-Cu (Copper Peptide)
GHK-Cu is the most studied of all longevity peptides for skin, wound healing, and gene expression. In 2010, Pickart and colleagues showed GHK-Cu resets the expression profile of around one third of human genes back toward a younger state.
Mechanism: Modulates gene expression, drives collagen synthesis, suppresses inflammatory cytokines, supports stem cell proliferation.
Typical protocol: 1 to 2mg subcutaneous daily, or topical for skin specifically.
Cost: $50 to $90 monthly.
Why it ranks second: Visible results within 8 to 12 weeks for skin, and the gene expression data is unique among peptides.
3MOTS-c
MOTS-c is a mitochondrial-derived peptide that signals improved metabolic flexibility, insulin sensitivity, and exercise capacity. In aging mice, MOTS-c supplementation extended healthspan and physical performance.
Mechanism: Targets the AMPK pathway, improves glucose disposal, supports mitochondrial biogenesis.
Typical protocol: 5 to 10mg subcutaneous, two to three times weekly for 8 to 12 weeks.
Cost: $130 to $200 monthly.
Why it ranks third: Hits metabolic aging, which is the second-most fundamental aging axis after cellular senescence.
4Thymosin Alpha-1
Immune decline (immunosenescence) is one of the most reliable markers of biological aging. Thymosin Alpha-1 restores T-cell function, particularly in elderly populations, and is FDA-approved in 35 countries for hepatitis B and immune support.
Mechanism: Modulates Th1/Th2 balance, increases T-cell maturation, improves natural killer cell activity.
Typical protocol: 1.6mg twice weekly, usually run in 12-week cycles.
Cost: $250 to $400 monthly.
Why it ranks fourth: Direct intervention on immune aging with regulatory backing in dozens of countries.
5BPC-157
BPC-157 is the all-purpose recovery peptide and earns a spot on this list because most aging-related decline runs through accumulated micro-injuries and inflammation that never fully resolve. BPC-157 closes that loop.
Mechanism: Promotes angiogenesis, accelerates tendon and ligament healing, repairs gut lining.
Typical protocol: 250 to 500mcg daily for 4 to 8 weeks per cycle.
Cost: $40 to $70 monthly.
Why it ranks fifth: Cheap, well-tolerated, and addresses the cumulative tissue damage that defines functional aging.
6CJC-1295 + Ipamorelin Stack
Growth hormone declines roughly 14% per decade after age 30. CJC-1295 with Ipamorelin restores pulsatile GH release without supraphysiological levels, which means lean mass support, better sleep, and improved skin.
Mechanism: CJC-1295 extends GHRH half-life, Ipamorelin selectively triggers GH pulses without cortisol or prolactin spikes.
Typical protocol: 100mcg of each, five nights per week, 12-week cycles with breaks.
Cost: $200 to $250 monthly for the stack.
Why it ranks sixth: Visible body composition and skin changes within 8 weeks. Results are real but the GH axis is downstream of the deeper aging mechanisms above.
7Tesamorelin
Tesamorelin is FDA-approved for visceral fat reduction in HIV patients, but its anti-aging applications come from its powerful effect on visceral adiposity, which is one of the strongest predictors of metabolic age.
Mechanism: GHRH analog with extended half-life, drives sustained GH and IGF-1 elevation.
Typical protocol: 1 to 2mg subcutaneous nightly.
Cost: $300 to $500 monthly.
Why it ranks seventh: The visceral fat reduction is real and meaningful, but cost and injection burden push it down for most users.
8Thymulin
Thymulin is another thymic peptide that restores immune function and has shown anti-inflammatory effects in aging models. Less famous than Thymosin Alpha-1 but cheaper.
Mechanism: Restores zinc-dependent immune signaling and reduces inflammatory tone.
Typical protocol: 100 to 200mcg daily for 4 to 6 weeks per cycle.
Cost: $80 to $150 monthly.
Why it ranks eighth: Solid mechanism, less human data than Thymosin Alpha-1, but a reasonable budget alternative.
9FOXO4-DRI (Senolytic)
FOXO4-DRI is the experimental senolytic peptide that targets and kills senescent cells, the so-called zombie cells that accumulate with age and pump out inflammatory signals.
Mechanism: Disrupts FOXO4-p53 binding in senescent cells, triggering selective apoptosis.
Typical protocol: 5mg subcutaneous, three doses across 7 days, repeated quarterly.
Cost: $150 to $300 per cycle.
Why it ranks ninth: Mechanistically exciting but human data is thin. Long-term safety still being characterized.
10NAD+ (Peptide-Adjacent)
Not technically a peptide but commonly bundled into anti-aging protocols and worth covering. NAD+ levels decline with age and supplementing them improves mitochondrial function and DNA repair.
Mechanism: Substrate for sirtuins and PARP enzymes, supports cellular energy and DNA repair.
Typical protocol: 100 to 500mg subcutaneous, two to three times weekly.
Cost: $150 to $300 monthly depending on dose.
Why it ranks tenth: Strong mechanism but injection-route NAD+ is uncomfortable and oral NAD precursors may be more practical for most people.
Stacking These for a Real Anti-Aging Protocol
Most serious longevity-focused researchers run a rotating protocol rather than stacking everything continuously. A common 12-month cadence looks like Epitalon for 20 days every quarter, GHK-Cu and BPC-157 daily as base layers, CJC-1295 with Ipamorelin in 12-week cycles with 4-week breaks, and one of the immune peptides (Thymosin Alpha-1 or Thymulin) once per year for a 12-week course.
Layering all ten compounds simultaneously is unnecessary, expensive, and increases the chance of side effects without proportional benefit.
Where to Source These Peptides
Sourcing matters more than the peptide choice. A counterfeit Epitalon at 30% purity does nothing. A clean batch with verifiable third-party testing actually moves the needle.
For Epitalon, GHK-Cu, MOTS-c, BPC-157, and the GH-axis peptides, the vendors that consistently show clean COAs are Apollo Peptide Sciences, Pantheon Peptides, and Amino Club. For the more specialty compounds like FOXO4-DRI and Thymulin, Limitless Life Peptides tends to carry them when others do not.
Realistic Expectations
Anti-aging peptides do not stop aging. They modulate specific aging mechanisms, and the visible result is usually subtle improvements in skin, recovery, sleep, energy, and resilience over 6 to 12 months. People who expect dramatic transformation in 4 weeks are disappointed. People who run protocols consistently for a year and check biomarkers (inflammation, GH/IGF-1, telomere length on TruDiagnostic if you care) usually see real changes.
The strongest signal in the long-running peptide community is from people who have stacked GHK-Cu, BPC-157, and the GH-axis peptides for 2+ years. They look measurably younger than peers, recover faster from training, and report better sleep. That is the realistic outcome.
Common Questions
Do longevity peptides interact with each other?
The compounds covered here do not have documented negative interactions with each other. The main practical consideration when running multiple longevity peptides is injection burden and the difficulty of isolating which compound is producing which effect if you start several simultaneously. Starting one compound at a time gives you a cleaner picture of what is working.
How long before longevity peptides show results?
Sleep and recovery effects from Epithalon often appear within the first week of a cycle. GHK-Cu skin effects appear over 4 to 12 weeks. Mitochondrial and metabolic effects from MOTS-c vary. The cellular longevity effects that are the point of the category are not perceptible. They compound over years of consistent use, not over weeks. This is the honest framing for anyone entering this space.
At what age should I start longevity peptides?
The research underlying Epithalon and GHK-Cu was primarily conducted in elderly subjects. Whether the same benefit applies to younger users is unknown. Most practitioners in this space suggest that longevity interventions are most relevant from the mid-30s onward, when the markers of cellular aging begin to accumulate meaningfully. GHK-Cu, with its skin and tissue effects, is used at earlier ages specifically for its cosmetic applications.
Vendors we use for longevity compounds
See the 2026 vendor scorecard for compound-by-compound availability.
Apollo Peptide Sciences Amino ClubGet the Dispatch
One research note, one vendor deal, once a week. Free dosing guide on confirm.
Double opt-in. Unsubscribe with one click. Research use only.